Epidemiology, pharmacoepidemiology, comparative efficacy and acceptability of drugs in treatment of attention deficit hyperactivity disorder in children and adolescents

Authors

  • Matej Štuhec Department of Clinical Pharmacy, Ormož Psychiatric Hospital, Ptujska cesta 33, 2270 Ormož, Slovenia; Faculty of Pharmacy. Department of Biopharmacy and Pharmacokinetics. University of Ljubljana. Aškerčeva cesta 7, 1000 Ljubljana, Slovenia and the Department of Pharmacology. Faculty of Medicine in Maribor. University of Maribor. Taborska Ulica 8, 2000 Maribor, Slovenia. , Oddelek za klinično farmacijo, Psihiatrična bolnišnica Ormož, Ptujska cesta 33, 2270 Ormož, Slovenija; Fakulteta za farmacijo. Katedra za biofarmacijo in farmakokinetiko. Univerza v Ljubljani. Aškerčeva cesta 7, 1000 Ljubljana, Slovenija in Katedra za farmakologijo. Medicinska fakulteta v Mariboru. Univerza v Mariboru. Taborska Ulica 8, 2000 Maribor, Slovenija. https://orcid.org/0000-0001-5909-6930 (unauthenticated)

DOI:

https://doi.org/10.18690/analipazu.6.1-2.37-43.2016

Keywords:

Attention Deficit Hyperactivity Disorder, pharmacotherapy, epidemiology, pharmacoepidemiology, meta-analyses

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is commonly diagnosed disorder in children and adolescents. In contrast to North America, where disorder is identified as ADHD, in numerous European countries Hyperkinetic disorder (HKM) is used. The exact cause of ADHD is unknown. The number of diagnosed patients with ADHD is increasing. Epidemiology and pharmacoepidemiology of ADHD in this part of Europe have not been well researched. ADHD treatment guidelines involves pharmacotherapy and non-pharmacological approaches. Effect sizes calculated from meta-analyses should not be the only evidence for clinicians when choosing ADHD medication, but they are a useful tool in choosing pharmacotherapy for ADHD patients.The main aim of this paper is to present the epidemiology and pharmacoepidemiology of ADHD in Slovenia and the comparative efficacy and acceptability of medications for ADHD using meta-analysis.

Author Biography

  • Matej Štuhec, Department of Clinical Pharmacy, Ormož Psychiatric Hospital, Ptujska cesta 33, 2270 Ormož, Slovenia; Faculty of Pharmacy. Department of Biopharmacy and Pharmacokinetics. University of Ljubljana. Aškerčeva cesta 7, 1000 Ljubljana, Slovenia and the Department of Pharmacology. Faculty of Medicine in Maribor. University of Maribor. Taborska Ulica 8, 2000 Maribor, Slovenia., Oddelek za klinično farmacijo, Psihiatrična bolnišnica Ormož, Ptujska cesta 33, 2270 Ormož, Slovenija; Fakulteta za farmacijo. Katedra za biofarmacijo in farmakokinetiko. Univerza v Ljubljani. Aškerčeva cesta 7, 1000 Ljubljana, Slovenija in Katedra za farmakologijo. Medicinska fakulteta v Mariboru. Univerza v Mariboru. Taborska Ulica 8, 2000 Maribor, Slovenija.

    Ormož, Ljubljana, Maribor. Slovenia. E-mail: matejstuhec@gmail.si

Downloads

Published

08.06.2022

Issue

Vol. 6 No. 1-2 (2016): ANALI PAZU

Section

Prispevki

How to Cite

Štuhec, M. (2022). Epidemiology, pharmacoepidemiology, comparative efficacy and acceptability of drugs in treatment of attention deficit hyperactivity disorder in children and adolescents. Anali PAZU, 6(1-2), 37-43. https://doi.org/10.18690/analipazu.6.1-2.37-43.2016

Most read articles by the same author(s)